Metformin, originally developed for diabetes, shows potential in anti-aging research, with a recent study suggesting it may reduce biological age. Advances in measuring biological age through the epigenetic clock allow for precise predictions about lifespan. As this testing approaches commercial availability, it raises intriguing questions about our understanding of aging and longevity.
